SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DRS/A - Draft Registration Statement: [Amend]
SEC Accession No. 0000950123-23-003601
Filing Date
2023-05-02
Accepted
2023-05-02 17:18:52
Documents
7

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS/A 2292882
2 GRAPHIC g241143g26s98.jpg GRAPHIC 168394
3 GRAPHIC g241143g29z30.jpg GRAPHIC 218614
4 GRAPHIC g241143g33a33.jpg GRAPHIC 125995
5 GRAPHIC g241143g37a37.jpg GRAPHIC 107358
6 GRAPHIC g241143g51j79.jpg GRAPHIC 73986
7 GRAPHIC g241143g86c02.jpg GRAPHIC 37470
  Complete submission text file 0000950123-23-003601.txt   3302946
Mailing Address 490 ARSENAL WAY, SUITE 200 WATERTOWN MA 02472
Business Address 490 ARSENAL WAY, SUITE 200 WATERTOWN MA 02472 (857) 760-0900
Neumora Therapeutics, Inc. (Filer) CIK: 0001885522 (see all company filings)

IRS No.: 844367680 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRS/A | Act: 33 | File No.: 377-05663 | Film No.: 23880485
SIC: 2836 Biological Products, (No Diagnostic Substances)